ResMed Inc
Company Profile
Business description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Contact
9001 Spectrum Center Boulevard
San DiegoCA92123
USAT: +1 858 836-5000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2025
Employees
9,980
Stocks News & Analysis
stocks
16 ASX stocks to buy and hold forever, revisited
stocks
This ASX200 reject could be a contrarian buying opportunity
stocks
A 15 step checklist from Buffett's forgotten inspiration
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,002.60 | 100.80 | -1.24% |
| CAC 40 | 7,988.96 | 47.05 | 0.59% |
| DAX 40 | 22,676.41 | 347.64 | 1.56% |
| Dow JONES (US) | 41,449.01 | 15.53 | 0.04% |
| FTSE 100 | 8,540.97 | 44.98 | 0.53% |
| HKSE | 23,600.31 | 181.83 | -0.76% |
| NASDAQ | 17,657.20 | 221.11 | 1.27% |
| Nikkei 225 | 36,819.09 | 25.98 | 0.07% |
| NZX 50 Index | 12,249.55 | 161.42 | -1.30% |
| S&P 500 | 5,609.61 | 37.54 | 0.67% |
| S&P/ASX 200 | 7,786.20 | 103.90 | -1.32% |
| SSE Composite Index | 3,371.92 | 7.90 | -0.23% |